CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 217 SEK 1.17% Market Closed
Market Cap: 5.2B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Capital Expenditures
-kr76.4m
CAGR 3-Years
-19%
CAGR 5-Years
-31%
CAGR 10-Years
-17%
Elekta AB (publ)
STO:EKTA B
Capital Expenditures
-kr1.6B
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Capital Expenditures
-kr47.2m
CAGR 3-Years
-67%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Capital Expenditures
-kr1.4B
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Capital Expenditures
-kr403m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Capital Expenditures
-kr12.6m
CAGR 3-Years
18%
CAGR 5-Years
-20%
CAGR 10-Years
-19%
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.2B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
265.65 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is CellaVision AB's Capital Expenditures?
Capital Expenditures
-76.4m SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Capital Expenditures amounts to -76.4m SEK.

What is CellaVision AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%

Over the last year, the Capital Expenditures growth was 13%. The average annual Capital Expenditures growth rates for CellaVision AB have been -19% over the past three years , -31% over the past five years , and -17% over the past ten years .

Back to Top